Sign Out
Boostagen is indicated for active booster immunization against tetanus, diphtheria and pertussis in individuals from the age of 3 years onwards.
Boostagen is indicated for maternal immunization in pregnant women for the prevention of pertussis in infants too young to be vaccinated and for pertussis immunization in healthcare providers to prevent nosocomial transmission to infants.
Boostagen should be used in accordance with official recommendations for booster and catch up vaccination against tetanus, diphtheria and pertussis.
Boostagen is not indicated for primary immunization.
Continue with Google